Genomic landscape of cancer in racially and ethnically diverse populations
- 28 November 2024
- journal article
- review article
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 26 (5) , 336-349
Abstract
Cancer incidence and mortality rates can vary widely among different racial and ethnic groups, attributed to a complex interplay of genetic, environmental and social factors. Recently, substantial progress has been made in investigating hereditary genetic risk factors and in characterizing tumour genomes. However, most research has been conducted in individuals of European ancestries and, increasingly, in individuals of Asian ancestries. The study of germline and somatic genetics in cancer across racial and ethnic groups using omics technologies offers opportunities to identify similarities and differences in both heritable traits and the molecular features of cancer genomes. An improved understanding of population-specific cancer genomics, as well as translation of those findings across populations, will help reduce cancer disparities and ensure that personalized medicine and public health approaches are equitable across racial and ethnic groups.Keywords
This publication has 168 references indexed in Scilit:
- The Contributions of Health Communication to Eliminating Health DisparitiesAmerican Journal of Public Health, 2004
- Human Leukocyte Antigen Gene Polymorphism and the Histocompatibility LaboratoryThe Journal of Molecular Diagnostics, 2001
- Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and FinlandNew England Journal of Medicine, 2000
- Loss of MHC class II expression is associated with a decrease of tumor-infiltrating T cells and an increase of metastatic potential of colorectal cancerPathology - Research and Practice, 2000
- High frequency of altered HLA class I phenotypes in invasive colorectal carcinomasTissue Antigens, 1998
- Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APCNature Genetics, 1997
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%Nature Genetics, 1996
- Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancerNature Genetics, 1996
- Enhanced immunological surveillance in mice heterozygous at the H-2 gene complexNature, 1975